Page 15 - AIH-1-4

Artificial Intelligence in Health Radiomics in early-stage lung cancer

References of a prediction model for overall survival after stereotactic
body radiation therapy for primary non-small cell
1. Chang JY, Mehran RJ, Feng L, et al. Stereotactic ablative lung cancer using radiomics analysis. Cancers (Basel).
radiotherapy for operable stage I non-small-cell lung 2022;14(16):3859.
cancer (revised STARS): Long-term results of a single-arm,
prospective trial with prespecified comparison to surgery. doi: 10.3390/cancers14163859
Lancet Oncol. 2021;22(10):1448-1457. 12. Luo LM, Huang BT, Chen CZ, et al. A combined model
doi: 10.1016/S1470-2045(21)00401-0 to improve the prediction of local control for lung cancer
patients undergoing stereotactic body radiotherapy based on
2. Li C, Wang L, Wu Q, et al. A meta-analysis comparing radiomic signature plus clinical and dosimetric parameters.
stereotactic body radiotherapy vs conventional radiotherapy Front Oncol. 2022;11:819047.
in inoperable stage I non-small cell lung cancer. Medicine
(Baltimore). 2020;99(34):e21715. doi: 10.3389/fonc.2021.819047
doi: 10.1097/MD.0000000000021715 13. Isoyama-Shirakawa Y, Yoshitake T, Ninomiya K, et al.
Combination of clinical factors and radiomics can predict
3. Jameson JL, Longo DL. Precision medicine-- local recurrence and metastasis after stereotactic body
personalized, problematic, and promising. N Engl J Med. radiotherapy for non-small cell lung cancer. Anticancer Res.
2015;372(23):2229-2234.
2023;43(11):5003-5013.
doi: 10.1056/NEJMsb1503104
doi: 10.21873/anticanres.16699
4. Bertolini M, Trojani V, Botti A, et al. Novel harmonization 14. Lafata KJ, Hong JC, Geng R, et al. Association of pre-
method for multi-centric radiomic studies in non-small cell treatment radiomic features with lung cancer recurrence
lung cancer. Curr Oncol. 2022;29(8):5179-5194.
following stereotactic body radiation therapy. Phys Med Biol.
doi: 10.3390/curroncol29080410 2019;64(2):025007.
5. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: doi: 10.1088/1361-6560/aaf5a5
Extracting more information from medical images using
advanced feature analysis. Eur J Cancer. 2012;48(4):441-446. 15. Li Q, Kim J, Balagurunathan Y, Qi J, et al. CT imaging
features associated with recurrence in non-small cell lung
doi: 10.1016/j.ejca.2011.11.036 cancer patients after stereotactic body radiotherapy. Radiat
6. Fave X, Cook M, Frederick A, et al. Preliminary investigation Oncol. 2017;12(1):158.
into sources of uncertainty in quantitative imaging features. doi: 10.1186/s13014-017-0892-y
Comput Med Imaging Graph. 2015;44:54-61.
16. Na F, Wang J, Li C, Deng L, Xue J, Lu Y. Primary
doi: 10.1016/j.compmedimag.2015.04.006 tumor standardized uptake value measured on F18-
7. Zhao B, Tan Y, Tsai WY, et al. Reproducibility of radiomics Fluorodeoxyglucose positron emission tomography is of
for deciphering tumor phenotype with imaging. Sci prediction value for survival and local control in non-small-
Rep. 2016;6:23428. cell lung cancer receiving radiotherapy: Meta-analysis.
J Thorac Oncol. 2014;9(6):834-842.
doi: 10.1038/srep23428
doi: 10.1097/JTO.0000000000000185
8. Mackin D, Fave X, Zhang L, et al. Measuring computed
tomography scanner variability of radiomics features. Invest 17. Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP,
Radiol. 2015;50(11):757-65. Wong CY. Revisiting the prognostic value of preoperative
(18)F-fluoro-2-deoxyglucose ((18)F-FDG) positron
doi: 10.1097/RLI.0000000000000180 emission tomography (PET) in early-stage (I & II) non-
9. Huynh E, Coroller TP, Narayan V, et al. Associations of small cell lung cancers (NSCLC). Eur J Nucl Med Mol
radiomic data extracted from static and respiratory-gated Imaging. 2010;37(4):691-698.
CT scans with disease recurrence in lung cancer patients doi: 10.1007/s00259-009-1291-x
treated with SBRT. PLoS One. 2017;12(1):e0169172.
18. Wu J, Aguilera T, Shultz D, et al. Early-stage non-small
doi: 10.1371/journal.pone.0169172 cell lung cancer: Quantitative imaging characteristics of
10. Kakino R, Nakamura M, Mitsuyoshi T, et al. Application and (18)F fluorodeoxyglucose PET/CT allow prediction of
limitation of radiomics approach to prognostic prediction distant metastasis. Radiology. 2016;281(1):270-278.
for lung stereotactic body radiotherapy using breath- doi: 10.1148/radiol.2016151829
hold CT images with random survival forest: A multi-
institutional study. Med Phys. 2020;47(9):4634-4643. 19. Pyka T, Bundschuh RA, Andratschke N, et al. Textural
features in pre-treatment [F18]-FDG-PET/CT are correlated
doi: 10.1002/mp.14380 with risk of local recurrence and disease-specific survival in
11. Sawayanagi S, Yamashita H, Nozawa Y, et al. Establishment early stage NSCLC patients receiving primary stereotactic

Volume 1 Issue 4 (2024) 9 doi: 10.36922/aih.3541